Courtney Andersen studies the role of estrogen receptor-alpha in ovarian cancer.
Chris Barnes investigates the structural details by which transcription factor activity regulates RNA Polymerase II during the universal process of eukaryotic gene expression.
Soma Jobaggy studies nitrated fatty acid pharmacology and the antioxidant response in hypertensive end-organ damage.
Allison Nagle studies growth factor receptor signaling in breast cancer.
Julie Myers-Irvin

Grants Developer, School of Engineering, University of Pittsburgh

Email:
myersirvinjm@upmc.edu

Graduated: 2005
Dissertation:
Characterization of Nuclear Matrix Alterations Involved in Bladder Cancer Progression


After graduation, in their own words:

Following graduation I did a post-doc at the McGowan Institute for Regenerative Medicine at Pitt. Deciding that a tenure track position was not where my heart was, I started to look for positions outside of that venue. I was hired by Pitt as a grant developer for faculty in the school of Health Sciences. After a few years I was recruited to my current position as a grant developer in the Department of Radiology, and am still at Pitt. I hope continued success to everyone.

STUDENT NEWS


UPCOMING EVENTS
11/27/2017 8:30 AM Molecular Pharmacology Journal Club
Lloyd Harvey


11/30/2017 12:00 PM Pharmacology & Chemical Biology Seminar Series
Jeffrey L. Brodsky, Ph.D.


12/4/2017 8:30 AM Molecular Pharmacology Journal Club
Andrew Lamade


Pharmacology and Chemical Biology Event Calendar

Program Achievements

Molecular Pharmacology Graduate Program Ranked #2 in National Research Council Rankings

Molecular Pharmacology Graduate Program Ranked #2 in Faculty Scholarly Productivity Index


Outcomes:  Time to disseration, last five graduating clasess:  4.5 years, Completion Rate: 84.8%

Ranked #12 in National of Institute of Health funding of departments of Pharmacology

Ranked in the top 15 in funding for twenty consecutive years




Back to Top